Who makes Nicotinamide, ABA and Zinc PCA?

Nicotinamide, ABA and Zinc PCA is developed by Rumah Sakit Pusat Angkatan Darat Gatot Soebroto.

What development phase is Nicotinamide, ABA and Zinc PCA in?

Nicotinamide, ABA and Zinc PCA is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Nicotinamide, ABA and Zinc PCA

Rumah Sakit Pusat Angkatan Darat Gatot Soebroto · FDA-approved active Small molecule Quality 0/100

At a glance

Generic name	Nicotinamide, ABA and Zinc PCA
Sponsor	Rumah Sakit Pusat Angkatan Darat Gatot Soebroto
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Efficacy and Tolerability of Nicotinamide Plus Cream for Moderate Acne Vulgaris in Indonesia (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Nicotinamide, ABA and Zinc PCA CI brief — competitive landscape report
Nicotinamide, ABA and Zinc PCA updates RSS · CI watch RSS
Rumah Sakit Pusat Angkatan Darat Gatot Soebroto portfolio CI